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ABSTRACT
Background: Human immunodeficiency virus (HIV) infection is a major global health problem. Tuberculosis 
and cryptococcal meningitis are the leading cause of death among people living with HIV. 
Aim: The purpose of this study was to determine whether any relationship exists between the occurrence 
of oral lesions and opportunistic infections among HIV-infected patients in Indian population.
Materials and methods: A cross-sectional analytical study was performed in 232 HIV-infected persons 
(148 males and 84 females, aged 20–60 years, mean 33.6 ± 2.3 years). c2 test and logistic regression 
were used for statistical analysis.
Results: Oral candidiasis was the most common oral lesion seen in 28.4% males and 22.6% females of 
HIV-infected persons, followed by hairy leukoplakia in 27% males and 20.2% females which was statistically 
significant. Tuberculosis (21.6%) followed by cryptococcosis (9.9%) and pneumocystis carinii pneumonia 
(4.7%) were the most commonly found opportunistic infections. Logistic regression analysis revealed  
a significant association, between the occurrence of tuberculosis and candidiasis (OR 2.3; 95% CI 1.4–2.9), 
cryptococcosis and candidiasis (OR 1.4; 95% CI 1.0–1.9), and pneumocystis carinii pneumonia with hairy 
leukoplakia (OR 1.6; 95% CI 1.0–2.9). Mean CD4 count was also less.
Conclusions: The results suggest a definite relationship in occurrence of oral lesions and opportunistic 
infections among HIV-infected patients.
(Int Marit Health 2014; 65, 3: 124–130)
Key words: HIV-infected patients, cross sectional study, CD4 counts, opportunistic infections,  
tuberculosis

INTRODUCTION
 Acquired immunodeficiency syndrome (AIDS) is an in-
fectious disease caused by the human immunodeficiency 
virus (HIV), and is characterised by profound immunosup-
pression that leads to opportunistic infections, secondary 
neoplasm and neurologic manifestations along with oral 
manifestations [1]. The magnitude of this modern plague 
is truly staggering. Already, more than 30 million people 
around the world have died of AIDS-related diseases [2]. 
In 2010, 2.7 million people were newly infected with HIV, 
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and 1.8 million men, women and children died of AIDS-re-
lated causes. Thirty four million people around the world 
are now living with HIV [3]. In 2009 it was estimated that 
2.4 million people were living with HIV in India, which equates 
to a prevalence of 0.3% [4]. While this may seem low, be-
cause India’s population is so large, it is third in the world 
after South Africa and Nigeria in terms of greatest number 
of people living with HIV [5]. With a population of around 
a billion, a mere 0.1% increase in HIV prevalence would 
increase the estimated number of people living with HIV 
by over half a million.
 People with advanced HIV infection are vulnerable to 
infections and malignancies that are called ‘opportunistic 
infections’ (OI) because they take advantage of the oppor-
tunity offered by a weakened immune system. There are 
many types of OI. Tuberculosis (TB) and a serious related 
disease, mycobacterium avium complex (MAC), are bac-
terial infections. Viral infections include cytomegalovirus 
(CMV) and hepatitis C, fungi causing thrush (candidiasis), 
cryptococcal meningitis, pneumocystis carinii pneumonia 
and histoplasmosis, and parasites causing cryptosporidiosis 
and toxoplasmosis [6].
Tuberculosis is the leading cause of death among peo-
ple living with HIV. Almost 1 in 4 deaths among people 
with HIV is due to TB. In 2010, 350,000 people died of 
HIV-associated TB. It is also the most common presenting 
illness among people living with HIV, including those who 
are taking antiretroviral treatment. There were an estimated 
1.1 million HIV positive new TB cases globally in 2010. 
At least one-third of the 34 million people living with HIV 
worldwide are infected with TB. Persons co-infected with 
TB and HIV are 21–34 times more likely to develop active 
TB disease than persons without HIV [7].
Cryptococcal meningitis has been reported as the most 
common OI of the central nervous system of Indian patients 
with HIV infection [8]. Mortality from developed countries, 
secondary to HIV associated cryptococcal meningitis is in 
the range of 10–30% while in developing countries the 
mortality rate is substantial, around 13–40% because of 
late presentation, limited access to antifungal therapy, 
and inability to adequately monitor intracranial pressure 
among many other reasons [9]. The reported prevalence of 
pneumocystis jiroveci pneumonia is much lower outside the 
United States among the approximately 38 million AIDS-in-
fected individuals worldwide. In Africa, pneumocystis jiroveci 
pneumonia occurs in only 9% of individuals with AIDS [10].
 Oral manifestations can be the first clinical sign of the 
infections and also determine the progression of disease. 
Awareness of the variety of oral disorders which can develop 
throughout the course of HIV infection and coordination of 
health care services between a physician and a dentist may 
improve the overall health of the patient [11]. We performed 
a task to check comprehensive literature but could not find 
any Indian study for association of oral manifestations with 
OI among HIV-infected individuals. Since the oral manifes-
tations of HIV are common and can be considered as indi-
cators of systemic diseases, the present study was carried 
out to investigate if there was a relationship between oral 
manifestations and OI among HIV-positive patients in Indian 
population.
MATERIALS AND METHODS
STUDY DESIgN AND STUDY POPULATION
This cross-sectional analytical study was conducted 
over 1-year period from January 2012 to December 2012. 
232 HIV-infected persons (148 males and 84 females, 
aged 20–60 years, mean 33.6 ± 2.3 years) were selected 
from those attending the outpatient department according 
to criteria.
Inclusion criteria
Patients had to satisfy all of the following inclusion 
criteria: (1) HIV-infection as documented by positive HIV 
ELISA (Merind Diagnostics, Belgium) and Western Blot (Bio-
technology kit, Singapore); (2) Ability and willingness of 
subject to understand study requirements and give written 
informed consent.
Exclusion criteria
Subject were considered ineligible for the study if any of 
the following criteria/s were satisfied: (1) Patients who had 
any systemic disease other than HIV; (2) Patient who were 
suffering from any psychological disorders; (3) Pregnant 
and lactating females; (4) Patients who were not willing for 
participation.
Ethical considerations
The research was conducted in full accordance with the 
World Medical Association Declaration of Helsinki. The study 
protocol was reviewed and approved by the Institutional Ethi-
cal Committee (A5368U10/22/12/2011). Written informed 
consent was obtained from all the study participants after 
explaining the nature and purpose of research.
Methodology
 Sociodemographic data (age, gender, educational sta-
tus, occupation and adverse oral habits) were obtained 
using a structured questionnaire. The source of infection 
was determined by asking the patients by indirectly ques-
tioning about their behaviour depending on condition and 
categorising them into different groups. The stage of HIV 
infection was categorised as: asymptomatic, symptomatic 
and AIDS according to the World Health Organisation (WHO) 
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clinical staging criteria. Immune status was determined 
by performing the absolute CD4 lymphocyte counts using 
flow cytometry (SRL, Ranbaxy laboratories, Mumbai) within 
2 weeks of the oral examination. WHO proposed the immu-
nological classification on the basis of CD4 count as none 
or not significant — Group 1 (> 500/mL), mild — Group 2 
(350–499/mL), advanced — Group 3 (200–349/mL) and 
severe — Group 4 (< 200/mL) [11]. Medication taken by 
patients was assessed from patient’s medical records. 
A single trained dental surgeon with a physician per-
formed clinical oral examination and systemic examination, 
respectively, and recorded the findings on presence of oral 
lesions and OI. Intra-oral examination was performed using 
disposable mouth mirrors, sterile gauze pads and incandes-
cent head-mounted light. The oral lesions were diagnosed ac-
cording to the criteria established by the European Commis-
sion Clearinghouse (presumptive approach) and WHO [12]. 
The following criteria were used to define common OI: pul-
monary TB: clinical features suggestive of TB with radio-
logical features compatible with TB on chest radiograph 
or computed tomographic (CT) scan and/or demonstration 
of acid-fast bacilli in sputum smears or growth of myco-
bacterium TB in sputum culture. Cryptococcal meningitis 
was defined as a clinical feature of meningitis/meningo-
encephalitis along with positive cerebrospinal fluid (CSF) 
cryptococcal antigen test or positive CSF India ink prepa-
ration or isolation of cryptococcus neoformans in the CSF 
culture. Pneumocystis jiroveci pneumonia: bilateral, diffuse 
interstitial infiltrates on chest radiograph or high-resolution 
CT, with hypoxemia (PaO2 < 12 kPa) and sputum smears/ 
/cultures negative for aerobic bacteria and acid-fast bacilli 
and/or demonstration of pneumocystis jiroveci in induced 
sputum. Tissue biopsy procedure was performed for diag-
nosing oral hairy leukoplakia.
STATISTICAL ANALYSIS
 The data obtained were analysed using SPSS (Statis-
tical Package for Social Sciences) version 15.0 (SPSS Inc., 
Chicago, Illinois, USA). A c2 test of association was used to 
find out the association between variables. Logistic regres-
sion with odds ratio (OR) and 95% confidence interval (CI) 
were calculated for all infections. A p-value of < 0.05 was 
considered statistically significant.
RESULTS
Table 1 shows the sociodemographics of 232 enrolled 
HIV seropositive patients. 148 (63.8%) were males and 84 
(36.2%) were females with a male to female ratio of 1.8:1. 
The maximum number of cases in males was in the 30 to 
40 years age group, while for females it was the 20 to 30 years 
age group (48.6% and 54.8%, respectively). The difference 
observed was statistically significant. A greater percentage 
(40.5%) of the population in both age groups had education 
up to primary school only which was statistically not signi-
ficant. A statistically significant association was found with 
the presence of HIV among truck drivers (32.4%) in males 
and housewives (71.4%) in females. Around 70% were 
smokers, 50% tobacco chewers, 58.1% alcohol drinkers and 
60.8% with combination of habits in males when compared 
to less than 10% prevalence of all these habits in females.
The main source of infection for both males and females 
(93.2% and 89.3%, respectively) was through the hetero-
sexual route (Table 2), followed by infection via blood trans-
fusion (2.7% in males and 3.6% in females). Table 3 shows 
the prevalence of HIV-related oral lesions by gender. Of the 
232 patients, 19.39% (25 males, 20 females) had no oral 
lesions. More males (83.1%) than females (76.2%) had oral 
lesions and this was statistically significant. Oral candidiasis 
was the most common oral lesion seen in 28.4% males and 
22.6% females of HIV infected persons, followed by hairy 
leukoplakia in 27% males and 20.2% females which was 
statistically significant. Other lesions found among the study 
subjects which were statistically significant include pseu-
domembranous and erythematous candidiasis, necrotizing 
ulcerative gingivitis, necrotizing ulcerative periodontitis and 
linear gingival erythema. The odds were almost two times 
higher in males than females for candidiasis and multiple 
oral manifestations. It was 4.2% more in males for hairy 
leukoplakia. This difference was statistically significant. The 
CD4 count was also assessed for 232 HIV-positive patients. 
The mean CD4 count of these patients was found to be 
201 cells/mm3 (males = 82 cells/mm3 and females = 
= 119 cells/mm3) (SD = 100 cells/mm3).
Table 4 shows the prevalence of HIV-related OI by gender. 
Of 232 (63,79%) patients (91 males, 57 females) were not 
affected with OI. More males (38.5%) than females (32.1%) 
had OI and this was statistically significant. Tuberculosis 
was the most common OI seen in 28.4% males and 19% 
females. This higher prevalence in males was statistically 
significant. Other OI include cryptococcosis (10.1% males 
and 9.5% females) and pneumocystis carinii pneumonia 
(5.4% males and 3.6% females). This difference observed 
between the genders with higher prevalence in males was 
statistically significant. The odds were 2.2, 1.5 and 1.1 ti-
mes higher in males than females for TB, cryptococcosis and 
pneumocystis carinii pneumonia, respectively.
Logistic regression analysis of the association, between 
the occurrence of oral lesions and OI is shown in Table 5. 
The occurrence of TB was found to be significantly associ-
ated with the presence of oral candidiasis (OR 2.8; 95% CI 
1.2–3.5; whereas the occurrence of pneumocystis carinii 
pneumonia was significantly associated with the presence of 
oral hairy leukoplakia (OR 1.6; 95% CI 1.0–2.9). There also 
seemed to be an association between the occurrence of TB 
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Table 1. Sociodemographic characteristics of the study population
Variable Male Female Total P
Age group:
20–30 51 (34.5%) 46 (54.8%) 97 (41.8%) 0.005*
30–40 72 (48.6%) 31 (36.9%) 103 (44.4%)
40–50 23 (15.5%) 06 (7.1%) 29 (12.5%)
50–60 2 (1.4%) 1 (1.2%) 3 (1.3%)
Educational status:
No formal education 16 (10.8%) 22 (26.2%) 38 (16.4%) 0.231
Primary school 60 (40.5%) 34 (40.5%) 94 (40.5%)
Secondary school 47 (31.8%) 18 (21.4%) 65 (28%)
College 25 (16.9%) 10 (11.9%) 35 (15.1%)
Occupation:
Business 28 (18.9%) 1 (1.2%) 29 (12.5%) 0.001*
Commercial sex worker 2 (1.4%) 10 (11.9%) 12 (5.2%)
Truck driver 48 (32.4%) – 48 (20.7%)
Healthcare worker 2 (1.4%) 1 (1.2%) 03 (1.3%)
Housewife – 60 (71.4%) 60 (25.9%)
Labourer 31 (20.9%) 7 (8.3%) 38 (16.4%)
Farmer 30 (20.2%) 1 (1.2%) 31 (13.4%)
Unemployed 3 (2.0%) 2 (2.4%) 5 (2.2%)
Student 2 (1.4%) 2 (2.4%) 4 (1.7%)
Others 2 (1.4%) – 2 (0.9%)
Adverse oral habits:
Smokers 102 (68.9%) 2 (2.4%) 104 (44.8%) 0.07
Tobacco chewers 74 (50%) 8 (9.5%) 82 (35.3%)
Alcohol consumption 86 (58.1%) 1 (1.2%) 87 (37.5%)
Combined habits 90 (60.8%) 6 (7.1%) 96 (41.4%)
Total (n = 232) 148 (63.8%) 84 (36.2%) 232 (100%)
Test applied: Chi-square/Fischer’s exact test; *p ≤ 0.05 (statistically significant)
Table 2. Distribution of HIV-positive patients according to source of infection
Source of infection Male (n = 148) Female (n = 84) Total (n = 232)
Heterosexual 138 (93.2%) 75 (89.3%) 213 (91.8%)
Homosexual 1 (0.7%) – 1 (0.4%)
Intravenous drug use 2 (1.4%) – 2 (0.9%)
Blood transfusion 4 (2.7%) 3 (3.6%) 3 (1.3%)
Vertical transmission – 3 (3.6%) 3 (1.3%)
Needle prick injuries 1 (0.7%) 1 (1.2%) 4 (1.7%)
Unknown 2 (1.4%) 2 (2.4%) 6 (2.6%)
and angular cheilitis (OR 1.8; 95% CI 1.1–2.9; p < 0.003). 
Cryptococcosis infection was also found to be significantly 
associated with the presence of oral candidiasis (OR 1.4; 
95% CI 1.0–1.9).
DISCUSSION
People living with HIV in India come from incredibly 
diverse backgrounds and cultures. In the present study the 
maximum number of cases belonged to the second and 
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Table 3. Prevalence of HIV-related oral lesions according to gender
Oral lesions Male (n = 148) Female (n = 84) Total (n = 232) Odds ratio 95% CI
Group I: Lesions most commonly associated with HIV infection
Any oral manifestation† 123 (83.1%) 64 (76.2%) 187 (80.6%) 2.1* 1.38–4.65
Oral candidiasis 42 (28.4%) 19 (22.6%) 61 (26.3%) 2.0* 1.42–2.93
 Pseudomembranous 31 (20.9%) 11 (13.1%) 42 (18.1%) 1.6* 1.23–4.32
 Erythematous 6 (4.1%) 2 (2.4%) 8 (3.4%) 1.7* 0.94–3.98
 Hyperplastic 3 (2%) 1 (1.2%) 4 (1.7%) 0.9 0.40–2.05
Angular cheilitis 12 (8.1%) 3 (3.6%) 15 (6.5%) 1.8 0.97–2.06
Oral hairy leukoplakia 40 (27%) 17 (20.2%) 57 (24.6%) 4.2* 1.60–8.30
Necrotizing ulcerative gingivitis 6 (4.1%) 3 (3.6%) 9 (3.9%) 1.2* 0.72–2.04
Necrotizing ulcerative periodontitis 7 (4.7%) 1 (1.2%) 8 (3.4%) 1.6* 1.26–6.82
Linear gingival erythema 33 (22.3%) 16 (19%) 49 (21.1%) 1.6* 1.09–2.32
Group II: Lesions less commonly associated with HIV infection
Melanotic hyperpigmentation 37 (25%) 15 (17.9%) 52 (22.4%) 1.4 0.86–2.12
Xerostomia 2 (1.4%) 1 (1.2%) 3 (1.3%) 0.7 0.44–1.65
Herpes zoster 1 (0.7%) – 1 (0.4%) 0.7 0.24–2.26
Group III: Lesions associated with HIV infection
Recurrent aphthous ulcers 7 (4.7%) 5 (6%) 12 (5.2%) 0.8 0.35–1.63
†Many patients had more than one oral manifestation; *indicates statistical significance at p < 0.05; CI — confidence interval
Table 4. Prevalence of opportunistic infections according to gender
Opportunistic infections Male (n = 148) Female (n = 84) Total (n = 232) Odds ratio 95% CI
Tuberculosis 34 (28.4%) 16 (19%) 50 (21.6%) 2.2* 1.60–3.29
Cryptococcosis 15 (10.1%) 8 (9.5%) 23 (9.9%) 1.5* 1.12–2.32
Pneumocystis carinii pneumonia 8 (5.4%) 3 (3.6%) 11 (4.7%) 1.1* 0.72–2.04
*Indicates statistical significance at p < 0.05; CI — confidence interval
third decades. HIV and AIDS affect all segments of India’s 
population, from children to adults, businessmen to home-
less people, female sex workers to housewives, and gay 
men to heterosexuals. There is no single ‘group’ affected 
by HIV. However, HIV prevalence among certain groups (sex 
workers, injecting drug users, truck drivers, migrant workers, 
men who have sex with men) remains high and is currently 
around 6 to 8 times that of the general population [13]. Oral 
manifestations were seen more in smokers (68.9%) which 
may be attributed to particulate matter, noxious chemicals, 
and heat that can modify more local factors. Similarly oral 
manifestations were more prevalent in tobacco chewers 
and alcohol drinkers (50% and 58.1%, respectively). No 
statistical significance was also observed for individual oral 
manifestations with gender, smoking, tobacco chewers and 
alcohol (p > 0.05).
In the study, the source of infection was mainly hetero-
sexual (92%). The vast majority of infections occur through 
heterosexual sex (80%), and is concentrated among high 
risk groups including sex workers, and injecting drug users 
as well as truck drivers and migrant workers. According to 
Joint United Nations Programme on HIV/AIDS (UNAIDS), 
there has been improvement over time. Between 1996 
and 2010 the rate of new HIV infections fell by 56% [14]. 
This trend is mainly due to a drop in infections in southern 
states; in other areas there has been no significant decline.
The occurrence of oral manifestations is favoured by 
immune deterioration. The overall prevalence of HIV-relat-
ed oral lesions in the study was 80.6%. These finding was 
similar to studies conducted in Thailand (77%) [15] and 
Nigeria (84%) [16]. In another Indian study the prevalence 
of oral manifestations were seen in 72.3% patients [17]. 
A statistically significant higher prevalence of oral lesions 
was observed in males (83.1%) than females (76.2%). This 
finding is similar to other studies where males had more 
oral manifestations [17–19]. In the present study, the most 
common oral manifestation of HIV-infected patients was 
candidiasis (26.3%).
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Table 5. Logistic regression analysis between oral lesions and 
opportunistic infections among HIV-infected subjects
Opportunistic infections Odds ratio 95% CI
Tuberculosis
Any oral lesions 2.8* 1.2–3.5
Candidiasis 2.3* 1.4–2.9
Angular cheilitis 1.8* 1.1–2.9
Hairy leukoplakia 1.2 1.7–3.3
Linear gingival erythema 0.9 0.6–1.8
Cryptococcosis
Any oral lesions 1.1 0.7–2.5
Candidiasis 1.4* 1.0–1.9
Angular cheilitis 0.7 0.2–0.9
Hairy leukoplakia 0.5 0.2–1.1
Linear gingival erythema 0.5 0.2–0.9
Pneumocystis carinii pneumonia
Any oral lesions 1.3 0.6–2.1
Candidiasis 1.5 0.7–2.3
Angular cheilitis 0.8 0.2–1.2
Hairy leukoplakia 1.6* 1.0–2.9
Linear gingival erythema 0.7 0.4–1.6
*Indicates statistical significance at p < 0.05; CI — confidence interval
In accordance with oral hairy leukoplakia, there are no 
as such symptoms associated with the lesion itself, although 
varied signs and symptoms may be associated with the 
underlying cause of immunosuppression. The lesion is 
a white patch, which almost exclusively occurs on the la-
teral surfaces of the tongue, although rarely it may occur 
on the buccal mucosa, soft palate, pharynx or oesophagus. 
The lesion may grow to involve the dorsal surface of the 
tongue. The texture is vertically corrugated (“hairy”) or 
thickly furrowed and shaggy in appearance. Oral hairy 
leukoplakia was observed in 24.6% patients. This figure 
is higher to studies conducted by Laurenco and Figueiredo 
(11.8%) and Pedreira et al. (9%) [20–22]. Previous studies, 
however, reported pseudomembranous candidiasis as the 
most common oral manifestation [23]. Even the recent 
studies have indicated a definite relationship between 
pseudomembranous candidiasis (mostly erythematous) 
and progressing HIV infection [23, 24]. The prevalence 
of pseudomembranous candidiasis is only 18.1% in the 
present study. This difference can be due to differences 
in the prescribed medications, the stages of the disease 
or the way of transmission of the infection. Also pseudo-
membranous and erythematous candidiasis are supposed 
to be better markers of immune suppression than any other 
oral lesions as indicated by Bodhade et al. [25].
 Opportunistic infections were once the leading cause of 
HIV/AIDS-related morbidity and mortality, but widespread 
use of highly active anti-retroviral therapy and OI prophy-
laxis has been highly effective in reducing the incidence of 
such infections [26]. Tuberculosis (21.6%) was the most 
common OI in the study population. This was significantly 
less than the 32% reported in a study on south Indian 
population [17]. Patients who had oral candidiasis were 
2.3 times at higher risk of having TB which was statistically 
significant. This is similar to the report from De Cock et 
al. (1992) [27] and Nittayananta et al. (2002) [18] where 
a significant association between the occurrence of oral 
candidiasis and TB was observed. In Asia, a region with 
60% of the world’s population and 72% of the global TB 
burden, HIV has been advancing rapidly in recent years, 
threatening a resurgence of TB [28]. HIV-infected individ-
uals with hairy leukoplakia had 1.6 times higher risk of 
having pneumocystis carinii pneumonia. The significant 
association between oral candidiasis and hairy leukoplakia 
with the occurrence of TB and pneumocystis carinii pneu-
monia suggests that these two oral lesions may be used 
as clinical indicators for prophylaxis against the diseases. 
The fact that oral candidiasis and hairy leukoplakia can 
be readily detected by trained clinicians in a standardised, 
objective fashion without complicated or expensive diag-
nostic techniques, further increases their utility [29]. An 
early and timely diagnosis will help in improved treatment 
planning and prognosis of patients. 
CONCLUSIONS
The results indicated that among the patients being 
infected HIV, there exists a relationship between the occur-
rence of oral lesions and OI. So, diagnosis of oral lesions 
is of utmost importance to help identify the underlying or 
predisposing diseases, if any. Frequent follow up of such 
patients may be required.
Physicians and other clinicians providing care for HIV-in-
fected individuals should be trained in the diagnosis of oral 
lesions so that counselling and medical management can 
be improvised. Dentists with regular intraoral examinations 
at frequent intervals can play a small but significant role of 
ensuring an effective integrated delivery of health services 
for HIV-infected patients. This can occur only if there is 
joint action/strategy between health care providers and 
various HIV-related government as well as non-government 
organisations.
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